This guideline advises on the management of patients with egg allergy. Most commonly egg allergy presents in infancy, with a prevalence of approximately 2% in children and 0.1% in adults.
To determine the efficacy and safety of AR201 in a characterized oral desensitization immunotherapy (CODIT™) regimen in hen egg-allergic subjects aged 4 to 26 years, inclusive.
This medicinal product is indicated for the diagnosis of allergic (IgE – mediated) diseases (type 1 in the classification of Coombs and Gell).
Recently published data from high-impact randomized controlled trials indicate the strong potential of strategies to prevent the development of food allergy in high-risk individuals, but guidance in the United States at present is limited to a policy for only the prevention of peanut allergy, despite other data being available and several other countries advocating early egg and peanut introduction.
Protein Sciences Corporation announced topline data showing that Flublok Quadrivalent � the quadrivalent version of FDA-approved trivalent Flublok influenza vaccine...
Early and regular ingestion of the common allergens, peanut and egg has been shown to be an effective allergy prevention strategy.
Recent randomized controlled trials aimed at the prevention of food allergy have led to sweeping changes in food allergy prevention guidelines. Emphasis is now on the introduction of potential food allergens, particularly peanut and egg, rather than avoidance.